Annexon CEO granted 1.25M stock options

Love Douglas reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Love Douglas reported acquisition or exercise transactions in this Form 4 filing.

Annexon, Inc. director and President & CEO Douglas Love reported receiving a grant of stock options covering 1,250,000 shares of the company’s stock. These are derivative securities, reflecting an equity incentive award rather than an open-market share purchase or sale.

According to the vesting terms, 1/48th of the option shares vest on each monthly anniversary starting on February 19, 2026, so the award becomes fully vested and exercisable on the fourth anniversary of that date. Vesting depends on Mr. Love’s continuous service with Annexon on each vesting date.

Insider Trade Summary

Grant/Award: 1,250,000 shares

Grant/Award 1 txn

Insider Love Douglas

Role PRESIDENT AND CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,250,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 1,250,000 contracts (Direct)

Footnotes (1)

1. F1. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

FAQ

What insider transaction did Annexon (ANNX) report for Douglas Love?

Annexon reported that President and CEO Douglas Love received a grant of stock options for 1,250,000 shares. This is an equity incentive award, not an open-market trade, and represents derivative securities linked to Annexon’s common stock.

How many Annexon (ANNX) shares are covered by Douglas Love’s new option grant?

The new stock option awarded to Douglas Love covers 1,250,000 shares of Annexon’s stock. This option represents a significant equity incentive and is structured to vest gradually over four years, aligning the CEO’s compensation with ongoing service to the company.

When do Douglas Love’s Annexon (ANNX) stock options begin vesting?

Douglas Love’s stock options begin vesting on February 19, 2026, the Vesting Commencement Date. From that date, one forty-eighth of the total option shares vest monthly, providing a steady vesting schedule tied to his continued service with Annexon.

Over what period will Douglas Love’s Annexon (ANNX) option grant fully vest?

The option grant will fully vest over four years from February 19, 2026. One forty-eighth of the 1,250,000 shares vests each month, so 100% of the award becomes exercisable on the fourth anniversary, assuming continuous service throughout the vesting period.

Is Douglas Love’s Annexon (ANNX) Form 4 transaction a stock purchase or sale?

The Form 4 shows an acquisition of derivative securities via a stock option grant, not a stock purchase or sale. The transaction code is “A,” indicating a grant or award, and the options give a right to buy shares subject to vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 07:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Love Douglas

(Last) (First) (Middle)

C/O ANNEXON, INC.

1400 SIERRA POINT PKWY, BLDG C, STE 200

(Street)

BRISBANE CA 94005

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Annexon, Inc. [ ANNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$5.1	02/19/2026		A		1,250,000		(1)	02/19/2036	Common Stock	1,250,000	$0	1,250,000	D

Explanation of Responses:

1. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.

	/s/ Jennifer Lew, Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.